Signant’s in-house clinical and digital health sciences experts discuss the key takeaways from the FDA’s draft guidance on the use of patient-reported outcomes in oncology clinical trials.
Watch the webinar recording to learn current patient-reported outcome measures (PROMs) labeling and oncology challenges, including:
- How to address PROM specificity
- Core measurement domains
- Ideal measurement timing and frequency
- Implications for eCOA design and implementation
Discover key recommendations, compliance strategies, and how technology can enhance data quality and patient-centric trial design.
